查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1404686

美國家庭輸液治療市場規模、佔有率、趨勢分析報告：按產品、按應用、細分市場預測，2024-2030 年

U.S. Home Infusion Therapy Market Size, Share & Trends Analysis Report By Product (Infusion Pumps, Needleless Connectors), By Application (Anti-Infective, Endocrinology), And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 116 Pages | 商品交期: 2-10個工作天內

價格

美國家庭輸液治療市場的成長與趨勢：

Grand View Research 的最新報告顯示，到 2030 年，美國家庭輸液治療市場預計將達到 318 億美元。

預計2024年至2030年該市場將以7.7%的複合年成長率擴張。老年人口的增加和癌症、免疫力缺乏、克隆氏症、感染疾病、脫水、營養缺乏、多發性硬化症、噁心和嘔吐等疾病盛行率的增加正在顯著推動市場成長。縮短住院時間的需求不斷成長以及老年人口中慢性病盛行率的上升正在推動成長。

院內感染（HAI）的增加也是預測期內推動美國家庭輸液治療產業成長的主要因素。根據美國疾病管制與預防中心的數據，每年約有 170 萬名住院患者感染醫療保健獲得性感染疾病(HCAI)，約 98,000 人（每 17 名患者中就有 1 人）死於感染疾病。為此，家庭輸液治療的需求大幅增加。

這一趨勢正在增加家庭輸液治療的技術創新，例如將電子健康記錄與醫療設備和輸液幫浦結合。電子健康記錄允許儲存、搜尋和修改醫療記錄，使醫療保健專業人員和患者更容易追蹤特定疾病的改善情況。

越來越多的患者更喜歡家庭醫療保健，因為與住院相比更具成本效益，這為行業參與者推出更多創新產品提供了機會。此外，更安全產品的推出最終將有助於美國家庭輸液治療市場的成長。由於COVID-19的出現，該國的家庭輸液主要企業已被活化。這一趨勢預計將進一步提振市場，因為該國眾多醫療機構預計將永久選擇居家輸液服務，以減輕醫院和其他醫療機構的病患入院負擔。

美國家庭輸液治療市場報告亮點

  • 與其他部門相比，輸液幫浦部門佔據了最大的銷售佔有率，因為它用於提供所需量的營養物質、藥物和其他必要的輸液，因此效率不斷提高。
  • 無針連接器市場預計將快速成長，因為它具有各種優點，例如細菌污染風險較小和對針刺傷害的保護更高。
  • 由於抗感染劑在居家醫療中廣泛用作抗真菌藥物、抗生素和抗病毒藥物，因此抗感染藥物在 2023 年佔據了最大的收益佔有率。
  • 由於甲狀腺和糖尿病等與內分泌系統相關的疾病的增加，內分泌領域預計將成為成長最快的領域。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章美國家庭輸液治療市場：細分分析，依產品，2018-2030

  • 2023 年及 2030 年產品市場佔有率分析
  • 美國家庭輸液治療市場（按產品），2023-2030 年
  • 2023-2030年市場規模、預測及趨勢分析

第4章美國家庭輸液治療市場：依應用細分分析，2018-2030

  • 2023 年和 2030 年應用市場佔有率分析
  • 美國家庭輸液治療市場（按應用），2023-2030
  • 2023年至2030年市場規模、預測與趨勢分析

第 5 章 家庭輸液治療市場：2018-2030 年各國市場

  • 2023-2030年市場規模、預測與趨勢分析
  • 美國

第6章家庭輸液治療市場-競爭分析

  • Competitive Dashboard Analysis-Impact Analysis
    • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭分類（主要創新者、市場領導、新興參與者）
    • 主要創新者名單
    • 市場領導者名單
    • 新晉球員名單
  • 公司市場分析（收益、產品系列、主要服務業、主要聯盟）
    • 按收益
  • Strategy Framework
  • 公司簡介
    • B. Braun Melsungen AG
    • Baxter
    • Caesarea Medical Electronics
    • CareFusion Corporation
    • Fresenius Kabi AG
    • ICU Medical, Inc.
    • JMS Co., Ltd.
    • Smiths Medical
    • Terumo Corporation
    • Coram LLC
    • Option Care Enterprises, Inc.
    • BioScrip, Inc.
    • BriovaRx Infusion Services
    • Paragon Healthcare, Inc.
Product Code: GVR-3-68038-956-2

U.S. Home Infusion Therapy Market Growth & Trends:

The U.S. home infusion therapy market size is expected to reach USD 31.8 billion by 2030, according to a new report by Grand View Research, Inc. The market is anticipated to expand at a CAGR of 7.7% from 2024 to 2030. The growing geriatric population and increasing prevalence of disorders, such as cancer, immune deficiencies, Crohn's disease, infections, dehydration, nutritional deficiencies, multiple sclerosis, nausea, and vomiting are majorly driving the market's growth. The increasing need for reduced hospital stays and the rising prevalence of chronic disorders in the geriatric population are driving the growth.

Growing cases of Hospital Acquired Infections (HAI) is another major factor driving the growth of the U.S. home infusion therapy industry over the forecast period. According to the U.S. Centers for Disease Control and Prevention, approximately 1.7 million admitted patients are affected annually by Healthcare Acquired infections (HCAIs) and around 98, 000 patients (1 in 17 patients) die due to the same. Due to this, the demand for home infusion therapy is increasing substantially.

Increasing innovations in home infusion therapy such as the incorporation of electronic healthcare records along with medical devices and infusion pumps are trending. It allows storage, retrieval, and alteration of medical records, making it easier for healthcare professionals and patients to track the improvements in a particular disorder.

Increasing patients' preference for home healthcare since it is cost-efficient in comparison with hospital stays is an opportunity for the industry players to launch more innovative products. Also, the introduction of safety products will ultimately help the growth of the U.S. home infusion therapy market. The advent of COVID-19 boosted the home infusion market in the country as many key players like Baxter, BD, ICU Medical, and Option Care Health, Inc reported revenue increases for their home infusion products and services in 2020 and 2021. This trend is expected to further boost the market as numerous healthcare settings in the country are expected to permanently opt for home infusion services to decrease patient admission burden in hospitals and other healthcare facilities

U.S. Home Infusion Therapy Market Report Highlights:

  • The infusion pumps segment held the largest revenue share compared to others due to the increasing use and efficiency in delivering required quantities of nutrition, medications, and other essential fluids
  • The needleless connectors segment is expected to witness the fastest growth owing to various benefits, such as less risk of bacterial contamination and higher protection against needle stick injuries
  • The anti-infective segment held the maximum revenue share in 2023 owing to its extensive use as an antifungal, antibiotic, and antiviral agent at home care
  • Endocrinology is predicted to be the fastest-growing segment owing to the growing number of conditions associated with the endocrine system, such as thyroid and diabetes

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation and Scope
    • 1.1.1 Estimates and forecast timeline
  • 1.2 Research Methodology
  • 1.3 Information procurement
    • 1.3.1 Purchased database:
    • 1.3.2 GVR's internal database
    • 1.3.3 Secondary sources
    • 1.3.4 Primary research
    • 1.3.5 Details of primary research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data analysis models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis (Model 1)
      • 1.6.1.1 Approach 1: Commodity Flow Approach
  • 1.7 List of Secondary Sources
  • 1.8 Objectives
    • 1.8.1 Objective 1
    • 1.8.2 Objective 2
    • 1.8.3 Objective 3
    • 1.8.4 Objective 4

Chapter 2 Executive Summary

  • 2.1 Market Outlook
  • 2.2 Penetration & Growth Prospect Mapping
  • 2.3 Market Dynamics
    • 2.3.1 Market driver analysis
      • 2.3.1.1 Increasing geriatric population
      • 2.3.1.2 Rising prevalence of chronic disorders
      • 2.3.1.3 Rapid technological advancements
      • 2.3.1.4 Growing incidence of hospital-acquired infections
      • 2.3.1.5 Home healthcare as a cost-effective alternative
    • 2.3.2 Market restrain analysis
      • 2.3.2.1 Presence of complicated reimbursement framework and reimbursement cuts
    • 2.3.3 Impact Of The 21st Century Cures Act And Projections For The Impact Of The Bipartisan Budget Act Of 2018.
    • 2.3.4 Trends For Home Infusion For Medicare Part B And Medicare Part D
  • 2.4 U.S. Home Infusion Therapy: Market Analysis Tools
    • 2.4.1 Industry analysis - Porter's
    • 2.4.2 PESTLE analysis
  • 2.5 U.S Home Infusion Therapy- Company Market Share Analysis 2023
  • 2.6 Major Deals & Strategic Alliances Analysis
  • 2.7 Procedure cost analysis/breakdown
  • 2.8 Technology Timeline
  • 2.9 Regulatory Framework
  • 2.10 Reimbursement framework

Chapter 3 U.S Home Infusion Therapy Market: Segment Analysis, By Product, 2018 - 2030 (USD Million)

  • 3.1 Product Market Share Analysis, 2023 & 2030
  • 3.2 U.S. Home Infusion Therapy Market, by Product, 2023 to 2030
  • 3.3 Market Size & Forecasts and Trend Analyses, 2023 to 2030
    • 3.3.1 Infusion pumps
      • 3.3.1.1 Infusion Pumps Market, 2018 - 2030 (USD Million)
      • 3.3.1.2 Elastomeric Market, 2018 - 2030 (USD Million)
      • 3.3.1.3 Electromechanical Market, 2018 - 2030 (USD Million)
      • 3.3.1.4 Gravity Market, 2018 - 2030 (USD Million)
      • 3.3.1.5 Others Market, 2018 - 2030 (USD Million)
    • 3.3.2 Intravenous sets
    • 3.3.3 Intravenous Sets Market, 2018 - 2030 (USD Million)
    • 3.3.4 Gravity Sets Market, 2018 - 2030 (USD Million)
    • 3.3.5 Dedicated Sets Market, 2018 - 2030 (USD Million)
    • 3.3.6 IV Cannulas
      • 3.3.6.1 IV Cannulas Market, 2018 - 2030 (Usd Million)
    • 3.3.7 Needleless Connectors
      • 3.3.7.1 Needleless Connectors Market, 2018 - 2030 (USD Million)

Chapter 4 U.S. Home Infusion Therapy Market: Segment Analysis, By Application, 2018 - 2030 (USD Million)

  • 4.1 Application Market Share Analysis, 2023 & 2030
  • 4.2 U.S. Home Infusion Therapy Market, by Application, 2023 to 2030
  • 4.3 Market Size & Forecasts and Trend Analyses, 2023 to 2030
    • 4.3.1 Anti-Infective
      • 4.3.1.1 Anti-infective market, 2018 - 2030 (USD Million)
    • 4.3.2 endocrinology
      • 4.3.2.1 ENDOCRINOLOGY MARKET, 2018 - 2030 (USD Million)
      • 4.3.2.2 Diabetes market, 2018 - 2030 (USD Million)
      • 4.3.2.3 Others market, 2018 - 2030 (USD Million)
    • 4.3.3 Hydration therapy
      • 4.3.3.1 hydration therapy market, 2018 - 2030 (USD Million)
      • 4.3.3.2 Athletes market, 2018 - 2030 (USD Million)
      • 4.3.3.3 Others market, 2018 - 2030 (USD Million)
    • 4.3.4 Chemotherapy
      • 4.3.4.1 CHEMOTHERAPY MARKET, 2018 - 2030 (USD Million)
    • 4.3.5 Enteral nutrition
      • 4.3.5.1 ENTERAL NUTRITION market, 2018 - 2030 (USD Million)
    • 4.3.6 Parenteral nutrition
      • 4.3.6.1 PARENTERAL NUTRITION market, 2018 - 2030 (USD Million)
    • 4.3.7 Specialty pharmaceuticals
      • 4.3.7.1 SPECIALTY PHARMACEUTICALS MARKET, 2018 - 2030 (USD Million)
    • 4.3.8 Others
      • 4.3.8.1 Others market, 2018 - 2030 (USD Million)

Chapter 5 Home Infusion Therapy Market: Country Market Analysis, By Product, 2018 - 2030 (USD Million)

  • 5.1 Market Size, & Forecasts and Trend Analysis, 2023 to 2030
  • 5.2 U.S.
    • 5.2.1 U.S. Home Infusion Therapy market, by product, 2018 - 2030 (USD Million)
    • 5.2.2 U.S. Home Infusion Therapy market, by Appliction, 2018 - 2030 (USD Million)

Chapter 6 Home Infusion Therapy Market - Competitive Analysis

  • 6.1 Competitive Dashboard Analysis - Impact Analysis
    • 6.1.1 Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2 Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
    • 6.2.1 List of key innovators
    • 6.2.2 List of market leader
    • 6.2.3 List of emerging players
  • 6.3 Company market position analysis (Revenue, product portfolio, key serviceable industries, key alliances)
    • 6.3.1 By Revenue
  • 6.4 Strategy Framework
  • 6.5 Company Profiles
    • 6.5.1 B. Braun Melsungen AG
      • 6.5.1.1 Company overview
      • 6.5.1.2 Financial performance
      • 6.5.1.3 Product benchmarking
      • 6.5.1.4 Strategic initiatives
    • 6.5.2 Baxter
      • 6.5.2.1 Company overview
      • 6.5.2.2 Financial performance
      • 6.5.2.3 Product benchmarking
      • 6.5.2.4 Strategic initiatives
    • 6.5.3 Caesarea Medical Electronics
      • 6.5.3.1 Company overview
      • 6.5.3.2 Product benchmarking
      • 6.5.3.3 Strategic initiatives
    • 6.5.4 CareFusion Corporation
      • 6.5.4.1 Company overview
      • 6.5.4.2 Financial performance
      • 6.5.4.3 Product benchmarking
      • 6.5.4.4 Strategic initiatives
    • 6.5.5 Fresenius Kabi AG
      • 6.5.5.1 Company overview
      • 6.5.5.2 Financial performance
      • 6.5.5.3 Product benchmarking
      • 6.5.5.4 Strategic initiatives
    • 6.5.6 ICU Medical, Inc.
      • 6.5.6.1 Company overview
      • 6.5.6.2 Financial performance
      • 6.5.6.3 Product benchmarking
      • 6.5.6.4 Strategic initiatives
    • 6.5.7 JMS Co., Ltd.
      • 6.5.7.1 Company overview
      • 6.5.7.2 Financial performance
      • 6.5.7.3 Product benchmarking
    • 6.5.8 Smiths Medical
      • 6.5.8.1 Company overview
      • 6.5.8.2 Financial performance
      • 6.5.8.3 Product benchmarking
      • 6.5.8.4 Strategic initiatives
    • 6.5.9 Terumo Corporation
      • 6.5.9.1 Company overview
      • 6.5.9.2 Financial performance
      • 6.5.9.3 Product benchmarking
      • 6.5.9.4 Strategic initiatives
    • 6.5.10 Coram LLC
      • 6.5.10.1 Company overview
      • 6.5.10.2 Product benchmarking
    • 6.5.11 Option Care Enterprises, Inc.
      • 6.5.11.1 Company overview
      • 6.5.11.2 Financial performance
      • 6.5.11.3 Product benchmarking
      • 6.5.11.4 Strategic initiatives
    • 6.5.12 BioScrip, Inc.
      • 6.5.12.1 Company overview
      • 6.5.12.2 Financial performance
      • 6.5.12.3 Product benchmarking
      • 6.5.12.4 Strategic initiatives
    • 6.5.13 BriovaRx Infusion Services
      • 6.5.13.1 Company overview
      • 6.5.13.2 Financial performance
      • 6.5.13.3 Product benchmarking
      • 6.5.13.4 Strategic initiatives
    • 6.6.14 Paragon Healthcare, Inc.
      • 6.6.14.1 Company overview
      • 6.6.14.2 Financial performance
      • 6.6.14.3 Product benchmarking

List of Tables

  • Table 1 List of secondary sources
  • Table 2 U.S. Home Infusion Therapy market, leading market players per region
  • Table 3 U.S. Home Infusion Therapy market, Regional Network Map
  • Table 4 U.S. Home Infusion Therapy market, market differentiating factor

List of Figures

  • Fig. 1 U.S. home infusion therapy market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Commodity flow analysis
  • Fig. 9 Market outlook (2023)
  • Fig. 10 Penetration & growth prospect mapping
  • Fig. 11 Market driver relevance analysis (Current & future impact)
  • Fig. 12 U.S. population over 60 years by age, 1900 - 2050
  • Fig. 13 Prevalence of chronic disease in the U.S.
  • Fig. 14 Treatment cost by healthcare setting (Average cost per day in USD)
  • Fig. 15 Market restraint relevance analysis (Current & future impact)
  • Fig. 16 Porter's five forces analysis
  • Fig. 17 PESTLE analysis
  • Fig. 18 U.S. Home Infusion Therapy market: Company market share analysis, 2023
  • Fig. 19 U.S. Home Infusion Therapy market: Company market share analysis, 2023
  • Fig. 20 U.S. Home Infusion Therapy Market: Product movement analysis
  • Fig. 21 U.S. Home Infusion Therapy Market Product Outlook: Key takeaways
  • Fig. 22 Infusion pumps market, 2018 - 2030 (USD Million)
  • Fig. 23 Elastomeric market, 2018 - 2030 (USD Million)
  • Fig. 24 Electromechanical market, 2018 - 2030 (USD Million)
  • Fig. 25 Gravity market, 2018 - 2030 (USD Million)
  • Fig. 26 Others market, 2018 - 2030 (USD Million)
  • Fig. 27 Intravenous sets market, 2018 - 2030 (USD Million)
  • Fig. 28 Intravenous sets market, 2018 - 2030 (USD Million)
  • Fig. 29 Dedicated sets market, 2018 - 2030 (USD Million)
  • Fig. 30 IV cannulas market, 2018 - 2030 (USD Million)
  • Fig. 31 Needleless connectors market, 2018 - 2030 (USD Million)
  • Fig. 32 U.S. home infusion therapy market: Application movement analysis
  • Fig. 33 Home infusion therapy market application outlook: Key takeaways
  • Fig. 34 Anti-infective market, 2018 - 2030 (USD Million)
  • Fig. 35 Endocrinology market, 2018 - 2030 (USD Million)
  • Fig. 36 Diabetes market, 2018 - 2030 (USD Million)
  • Fig. 37 Others market, 2018 - 2030 (USD Million)
  • Fig. 38 Hydration therapy market, 2018 - 2030 (USD Million)
  • Fig. 39 Athletes market, 2018 - 2030 (USD Million)
  • Fig. 40 Others market, 2018 - 2030 (USD Million)
  • Fig. 41 Chemotherapy market, 2018 - 2030 (USD Million)
  • Fig. 42 Enteral nutrition market, 2018 - 2030 (USD Million)
  • Fig. 43 Parenteral nutrition market, 2018 - 2030 (USD Million)
  • Fig. 44 Specialty pharmaceuticals market, 2018 - 2030 (USD Million)
  • Fig. 45 Others market, 2018 - 2030 (USD Million)
  • Fig. 46 U.S. Country Dynamics
  • Fig. 47 Recent Developments & Impact Analysis
  • Fig. 48 Strategy Framework